Table 5.
Participant |
Week 0 Total daily dose |
Week 16 Total daily dose |
Participants with diabetes medications discontinued (n = 7 of 21) | ||
5 | glipizide 10 mg metformin 1000 mg |
none |
6 | glipizide 20 mg metformin 1500 mg |
none |
7 | metformin 2000 mg rosiglitazone 8 mg |
none |
9 | metformin 1000 mg | none |
15 | metformin 1000 mg | none |
22 | metformin 1000 mg | none |
24 | metformin 1000 mg | none |
Participants with diabetes medications reduced (n = 10 of 21) | ||
3 | 70/30 insulin 50 units metformin 1000 mg |
metformin 1000 mg |
11 | metformin 2000 mg glyburide 20 mg |
metformin 2000 mg |
16 | metformin 2000 mg pioglitazone 45 mg glipizide 20 mg |
metformin 2000 mg |
21 | metformin 1500 mg pioglitazone 30 mg |
metformin 1000 mg |
8 | NPH 145 units metformin 1000 mg |
NPH 25 units metformin 1000 mg |
13 | 70/30 insulin 70 units metformin 2550 mg |
70/30 insulin 35 units metformin 2550 mg |
23 | 70/30 insulin 110 units pioglitazone 45 mg |
70/30 insulin 80 units pioglitazone 45 mg metformin 1000 mg |
25 | NPH 70 units, R 30 units metformin 2000 mg pioglitazone 45 mg |
NPH 8 units metformin 2000 mg pioglitazone 45 mg |
27 | 70/30 insulin 86 units metformin 2000 mg |
70/30 insulin 18 units metformin 2000 mg |
28 | NPH insulin 110 units lispro insulin 90 units glipizide 20 mg |
NPH insulin 30 units glipizide 20 mg |
Participants with diabetes medications unchanged (n = 4 of 21) | ||
1 | none | none |
2 | metformin 1700 mg | metformin 1700 mg |
10 | none | none |
26 | metformin 2000 mg | metformin 2000 mg |